This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hangzhou Zede Pharma-Tech Co. Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Work of Robert Charles Hider in Antiparkinsonian Drug Development
Introduction: Robert Charles Hider, an accomplished inventor based in London, GB, has made significant contributions in the field of pharmaceuticals. With a focus on developing innovative treatments for neurological disorders, Hider is best known for his groundbreaking patent in the synthesis of a novel compound with potential therapeutic applications in treating Parkinson's disease.
Latest Patents: Hider holds one prominent patent, which is titled "3,4-dihydroxy-N-(1'-benzyl-2′-hydroxyethyl)-2-methylpyridine chloride, and synthesis and use thereof." This invention details a one-step reaction process to prepare 3,4-dihydroxyl-N-(1′-benzyl-2′-hydroxyethyl)-2-methyl pyridine chloride, including its pharmaceutically acceptable salts. The compound has demonstrated promising antiparkinsonian activity through animal testing, positioning it as a potential drug candidate for patients suffering from Parkinson's disease.
Career Highlights: Throughout his career, Robert Charles Hider has focused on advancing pharmaceutical research, particularly targeting diseases that significantly impact the quality of life, such as Parkinson's disease. His innovative approaches have set him apart in the industry, with research tailored towards developing effective treatment options.
Collaborations: Hider is currently associated with Hangzhou Zede Pharma-Tech Co. Ltd., where he works alongside notable colleagues, including Yongping Yu and Xin Yuan. Their collaborative efforts aim to further research and development initiatives for new pharmaceutical compounds that can bring about positive changes in patient care.
Conclusion: Robert Charles Hider's contributions to drug development through his patented innovations signify a step forward in treating Parkinson's disease. His dedication to research and collaboration with other industry professionals highlights the importance of innovative thinkers in advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile